Home > Healthcare > Pharmaceuticals > Drug Delivery > Autoinjectors Market

Autoinjectors Market Trends

  • Report ID: GMI5412
  • Published Date: Mar 2023
  • Report Format: PDF

Generic autoinjectors are available on the market, although the availability and accessibility may vary depending on the region and the specific medication type. In some cases, the original manufacturer may have exclusive rights to produce and sell the autoinjector for a certain period, known as a patent. Once the patent has expired, other manufacturers may be able to produce and sell generic versions of the autoinjector. In some countries, regulatory agencies such as the FDA in the U.S. or the EMA in Europe may mandate that generic autoinjectors meet certain standards for safety and effectiveness before they can be approved for sale. This process can take some time and may involve clinical trials and other testing. Furthermore, the strong presence of key market players that are proactively involved in innovative type development and launches will fuel industry growth during the anticipated timeframe.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market share for autoinjectors was accounted at more than USD 55 billion in 2022 and is expected to record over 13% CAGR from 2023 to 2032.

Autoinjectors market share from the anaphylaxis therapy segment is forecasted to reach over USD 10 billion by end of 2032 owing to the rising prevalence and occurrence of anaphylaxis and food allergies.

Middle East & Africa autoinjectors industry is expected to reach over USD 12 billion by 2032 owing to the significant investments made in the development of new products by regional manufacturers.

AbbVie Inc., GlaxoSmithKline Plc., Mylan, Amgen, Becton, Ypsomed, Dickinson and Company, Eli Lilly and Company, Johnson & Johnson, and Antares Pharma, are some of the leading companies in the autoinjectors business.

Autoinjectors Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 230
  • Countries covered: 15
  • Pages: 175
 Download Free Sample